6 research outputs found
Additional file 1: Table S1. of Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Inclusion and exclusion criteria for patients with sHTG for detailed analyses. Table S2. List of lipid-related genes analyzed in peripheral blood mononuclear cells from patients with severe hypertriglyceridemia. Table S3. Baseline biochemical characteristic of 65 patients with severe hypertriglyceridemia. Table S4. Combinations of medications used at end of study among the 65 patients with hypertriglyceridemia. Table S5. Characteristics of the six patients with hypertriglyceridemia subjected to in-depth molecular analyses. (PDF 258 kb
Additional file 1: Table S1. of Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
Inclusion and exclusion criteria for patients with sHTG for detailed analyses. Table S2. List of lipid-related genes analyzed in peripheral blood mononuclear cells from patients with severe hypertriglyceridemia. Table S3. Baseline biochemical characteristic of 65 patients with severe hypertriglyceridemia. Table S4. Combinations of medications used at end of study among the 65 patients with hypertriglyceridemia. Table S5. Characteristics of the six patients with hypertriglyceridemia subjected to in-depth molecular analyses. (PDF 258 kb
Baseline characteristics.
<p>Data are given as median (min-max) except when percentage is indicated.</p><p>HbA1c: n = 18 (high HDL); FFA: n = 18 (high HDL); LDL: n = 14 (low HDL).</p><p>Low and High HDL groups.</p
Levels of serum PON1 activity oxLDL and PBMC gene expression of PON2.
<p>Serum PON1 activity (A), PBMC gene expression levels of PON2 (B), serum oxLDL levels (C) in subjects with low HDL cholesterol levels (n = 15) and subjects with high HDL cholesterol levels (n = 19; n = 18 for PON1 activity and oxLDL). The horizontal bars represent median values.</p
PBMC gene expression levels of cholesterol efflux mediators.
<p>ABCA1 (A), ABCG1 (B), SR-B1 (C), CD36 (D) and SR-A (E) in subjects with low HDL cholesterol levels (n = 15) and subjects with high HDL cholesterol levels (n = 19). The horizontal bars represent median values.</p
Additional file 1: of Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study
mRNA level at fasting (0hOGTT) and after 2hOGTT and fold change from fasting in the whole study population at baseline. Data for 0hOGTT and 2hOGTT is given as 2−∆Ct (normalized for TBP). Data for fold change is given as 2−∆∆Ct (normalized for TBP and 0hOGTT values). All values are presented as medians with 25th–75th percentiles. (DOCX 21.4 kb